Forge Genetics: Cutting through the genetic engineering patent thicket.
Companies looking to get innovative biology to patients around the world need to be aware that it takes a 360-degree view of the intellectual property requirements, and in the case of CRISPR this landscape is becoming more and more convoluted, with companies scrambling to renegotiate licensing laws for GMOs to use in research and industry. Taken together, this points towards an opportunity for Forge Genetics to position themselves perfectly, to create a novel, gold-standard gene-editing technology, supporting innovation throughout the global biotechnology industry.
![](https://cdn.prod.website-files.com/65690a8d09fa6cc6639b7b08/66602e54c873c2d0feabc120_my%20profile%20picture.jpg)
Aonghus Topham
July 11, 2024